Clinical Trial Update: The Quietude Study: Quetiapine Use for Agitated Depression [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating quetiapine for agitation in major depressive disorder was terminated early.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Quetiapine (Seroquel) (quetiapine)

Snippet

Sponsor: Physicians Research And Education Network | Conditions: Depression With Prominent Agitation | Phase 3 | Status: TERMINATED